Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 19, 2010 - Issue 11
Submit an article Journal homepage
558
Views
18
CrossRef citations to date
0
Altmetric
Drug Evaluations

Nalmefene for treatment of alcohol dependence

Michael Soyka University of Munich, Psychiatric Hospital, Nussbaumstr. 7, D-80336 Munich, Germany [email protected]; Private Hospital Meiringen, Directorate, Willigen, Meiringen, 3860, Switzerland [email protected]
&
Susanne Rösner University of Munich, Psychiatric Hospital, Nussbaumstr. 7, D-80336 Munich, Germany [email protected]
Pages 1451-1459 | Published online: 25 Sep 2010

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Juliette Salles, Camille Ponté & Laurent Schmitt. (2019) Psychotic Decompensation During Nalmefene Treatment in a Patient With Schizoaffective Disorder: A Case Report. Journal of Dual Diagnosis 15:2, pages 118-121.
Read now
Raye Z. Litten, Bonnie B. Wilford, Daniel E. Falk, Megan L. Ryan & Joanne B. Fertig. (2016) Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety. Substance Abuse 37:2, pages 286-298.
Read now
Panagiotis Oulis & George Konstantakopoulos. (2012) Efficacy and safety of pregabalin in the treatment of alcohol and benzodiazepine dependence. Expert Opinion on Investigational Drugs 21:7, pages 1019-1029.
Read now
Thomas Hillemacher, Annemarie Heberlein, Marc AN Muschler, Stefan Bleich & Helge Frieling. (2011) Opioid modulators for alcohol dependence. Expert Opinion on Investigational Drugs 20:8, pages 1073-1086.
Read now
Michael Soyka, Henry R. Kranzler, Wim van den Brink, John Krystal, Hans-Jürgen Möller & Siegfried Kasper. (2011) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence. The World Journal of Biological Psychiatry 12:3, pages 160-187.
Read now

Articles from other publishers (13)

Peng-Sheng Ting, Ahmet Gurakar, Jason Wheatley, Geetanjali Chander, Andrew M. Cameron & Po-Hung Chen. (2021) Approaching Alcohol Use Disorder After Liver Transplantation for Acute Alcoholic Hepatitis. Clinics in Liver Disease 25:3, pages 645-671.
Crossref
Marta Torrens, Francina Fonseca, Fernando Dinamarca, Esther Papaseit & Magi Farré. 2021. Textbook of Addiction Treatment. Textbook of Addiction Treatment 241 258 .
Niamh Fitzgerald, Kathryn Angus, Andrew Elders, Marisa Andrade, Duncan Raistrick, Nick Heather & Jim McCambridge. (2016) Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers. Addiction 111:8, pages 1477-1487.
Crossref
G. Milano, V. Zavan, W. M. Natta, A. Martelli & F. Mattioli. (2016) Clinical experience about an unexpected adverse event during nalmefene treatment in two patients with alcohol use disorder. Journal of Clinical Pharmacy and Therapeutics 41:1, pages 97-100.
Crossref
Dieter Seifert. 2015. Psychiatrische Begutachtung. Psychiatrische Begutachtung 389 403 .
Marta Torrens, Francina Fonseca, Liliana Galindo & Magi Farré. 2015. Textbook of Addiction Treatment: International Perspectives. Textbook of Addiction Treatment: International Perspectives 467 500 .
Zheng Yong, Xiang Gao, Wentao Ma, Huajing Dong, Zehui Gong & Ruibin Su. (2014) Nalmefene reverses carfentanil-induced loss of righting reflex and respiratory depression in rats. European Journal of Pharmacology 738, pages 153-157.
Crossref
Wenzel Schicho & Oliver Pogarell. (2013) Wichtige Ergänzung zur Rezidivprophylaxe und Trinkmengenreduktion. DNP - Der Neurologe und Psychiater 14:11, pages 62-69.
Crossref
Giovanni Martinotti, Marco Di Nicola, Daniela Tedeschi, Antonino Callea, Massimo Di Giannantonio & Luigi Janiri. (2013) Craving Typology Questionnaire (CTQ): A scale for alcohol craving in normal controls and alcoholics. Comprehensive Psychiatry 54:7, pages 925-932.
Crossref
M. Gahr, M.A. Kölle & C. Schönfeldt-Lecuona. (2012) Rückfallprävention bei Alkoholabhängigkeit: Acamprosat und Naltrexon als kombinierte pharmakologische StrategieRelapse prevention in alcohol dependence: acamprosate and naltrexone as a combined pharmacological strategy. Der Nervenarzt 84:5, pages 584-589.
Crossref
Nicolas Marie & Florence Noble. (2012) Dépendance aux drogues : avancées de la neurobiologie et perspectives thérapeutiques. La Presse Médicale 41:12, pages 1259-1270.
Crossref
Falk Kiefer & Michael Soyka. 2012. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie 733 749 .
Louis A. Pagliaro & Ann Marie Pagliaro. 2011. Handbook of Child and Adolescent Drug and Substance Abuse. Handbook of Child and Adolescent Drug and Substance Abuse 371 453 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.